— Know what they know.
Not Investment Advice
Also trades as: 0HR2.L (LSE) · $vol 1M

CME NASDAQ

CME Group Inc.
1W: -0.6% 1M: +11.5% 3M: +10.6% YTD: +8.8% 1Y: +9.4% 3Y: +51.5% 5Y: +61.0%
$293.48
-14.58 (-4.73%)
 
Weekly Expected Move ±2.9%
$288 $297 $306 $314 $323
NASDAQ · Financial Services · Financial - Data & Stock Exchanges · Tech Score Buy · Power 72 · $105.5B mcap · 355M float · 0.687% daily turnover · Short 39% of daily vol
Credit Risk of going bust: not rated, financial company (lending is its business) Bonds: $48.2M held by 114 funds, 36 bp over Treasuries → details ▾
Not rated: lending and leverage are a financial company's business, which the model misreads.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
66.8 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 12.6%  ·  5Y Avg: 11.4%
Cost Advantage
74
Intangibles
67
Switching Cost
48
Network Effect
65
Scale ★
90
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CME has a Narrow competitive edge (66.8/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Efficient Scale. ROIC of 12.6% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$321
Low
$342
Avg Target
$367
High
Based on 5 analysts since Oct 21, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 15Hold: 18Sell: 4Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$316.73
Analysts11
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-22 Piper Sandler — $295 $330 +35 +11.6% $295.79
2026-10-22 Wells Fargo Daniel Welden $315 $333 +18 +12.6% $295.79
2026-10-22 Morgan Stanley Michael Cyprys $337 $359 +22 +21.4% $295.79
2026-10-22 CLSA — Initiated $367 — +24.1% $295.79
2026-10-22 Barclays Benjamin Budish $281 $321 +40 +8.5% $295.79
2026-10-14 Wells Fargo Daniel Welden $301 $315 +14 +13.3% $278.03
2026-10-09 Morgan Stanley — $330 $337 +7 +21.9% $276.44
2026-10-07 Barclays — $316 $281 -35 +4.0% $270.18
2026-10-05 UBS Alex Kramm $260 $270 +10 +2.6% $263.14
2026-10-01 Wells Fargo Daniel Welden Initiated $301 — +13.5% $265.10
2026-08-19 Deutsche Bank — $300 $270 -30 -0.6% $271.54
2026-07-23 Morgan Stanley Michael Cyprys $324 $330 +6 +30.5% $252.80
2026-07-15 Piper Sandler — $320 $295 -25 +21.1% $243.61
2026-07-10 Morgan Stanley — $353 $324 -29 +36.4% $237.46
2026-07-06 UBS Alex Kramm $310 $260 -50 +9.9% $236.60
2026-06-17 Piper Sandler Patrick Moley $329 $320 -9 +29.0% $248.12
2026-06-15 Piper Sandler Patrick Moley $225 $329 +104 +22.8% $267.85
2026-06-11 Redburn Partners — Initiated $323 — +22.4% $263.80
2026-04-23 Morgan Stanley Michael Cyprys $362 $353 -9 +25.0% $282.44
2026-04-23 Barclays — $312 $316 +4 +10.6% $285.71
2026-04-10 Morgan Stanley — $340 $362 +22 +22.8% $294.81
2026-02-06 UBS — $280 $310 +30 +4.2% $297.38
2026-02-05 RBC Capital Ashish Sabadra $235 $302 +67 +0.5% $300.42
2026-02-05 Morgan Stanley — $319 $340 +21 +15.4% $294.62
2026-02-05 Barclays Benjamin Budish $304 $312 +8 +5.9% $294.62
2026-01-15 Morgan Stanley — $320 $319 -1 +16.7% $273.41
2025-12-22 Morgan Stanley Michael Cyprys $314 $320 +6 +18.9% $269.09
2025-12-12 Barclays — $280 $304 +24 +11.6% $272.42
2025-10-23 Morgan Stanley Michael Cyprys $312 $314 +2 +16.5% $269.50
2025-10-23 UBS Alex Kramm $285 $280 -5 +4.6% $267.81
2025-10-23 Deutsche Bank — $193 $300 +107 +11.3% $269.59
2025-10-13 Raymond James Patrick O'Shaughnessy $287 $307 +20 +13.1% $271.45
2025-10-08 Barclays — $298 $280 -18 +6.2% $263.60
2025-10-01 Morgan Stanley — $196 $312 +116 +18.0% $264.46
2025-09-08 UBS Alex Kramm $250 $285 +35 +8.9% $261.78
2025-07-24 Barclays Benjamin Budish $231 $298 +67 +7.5% $277.18
2025-03-10 Raymond James Patrick O'Shaughnessy $235 $287 +52 +12.7% $254.57
2024-10-24 Oppenheimer Owen Lau Initiated $258 — +13.4% $227.43
2024-10-24 Barclays Benjamin Budish $209 $231 +22 +1.7% $227.14
2024-10-03 Citigroup Christopher Allen $280 $250 -30 +11.8% $223.57
2024-09-26 RBC Capital Ashish Sabadra Initiated $235 — +7.6% $218.47
2024-09-03 Bank of America Securities Craig Siegenthaler Initiated $177 — -18.0% $215.74
2024-07-25 Deutsche Bank Brian Bedell $210 $193 -17 -3.0% $198.92
2024-07-25 Piper Sandler Patrick Moley $250 $225 -25 +12.8% $199.38
2024-07-25 Barclays Benjamin Budish $228 $209 -19 +6.0% $197.25
2024-06-05 UBS Alex Kromm $240 $250 +10 +22.7% $203.78
2024-04-25 Rosenblatt Securities Andrew Bond $171 $187 +16 -12.0% $212.59
2024-04-25 Barclays Benjamin Budish Initiated $228 — +7.2% $212.59
2024-04-05 Deutsche Bank Brian Bedell $212 $210 -2 -1.0% $212.21
2023-02-07 Credit Suisse — $210 $198 -12 +13.3% $174.76

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A-
Oct 27, 2026
DCF
4
ROE
5
ROA
4
D/E
4
P/E
2
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CME receives an overall rating of A-. Strongest factors: DCF (4/5), ROE (5/5), ROA (4/5), D/E (4/5). Areas of concern: P/E (2/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-01 B+ A-
2026-06-16 B B+
2026-06-15 B+ B
2026-06-03 B B+
2026-05-11 B+ B
2026-04-24 A- B+
2026-04-22 B+ A-
2026-04-01 B B+
2026-03-30 B+ B
2026-03-04 B B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 59 Grade A+
Profitability
75
Balance Sheet
60
Earnings Quality
82
Growth
59
Value
53
Momentum
78
Safety
65
Cash Flow
84
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CME scores highest in Cash Flow (84/100) and lowest in Value (53/100). An overall grade of A+ places CME among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman-B Score
2.96
Grey Zone
Piotroski F-Score
8/9
✓ ✓ ✓ ✓ ✓ ✗ ✓ ✓ ✓
Beneish M-Score
-3.62
Unlikely Manipulator
Ohlson O-Score
-6.79
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
AA-
Score: 83.6/100
Trend: Stable
Earnings Quality
100/100
OCF/NI: 1.00x
Accruals: -0.0%
The Altman-B Score replaces the traditional Z-Score for banks and financial institutions. It weights equity-to-assets, return on assets, retained earnings, market value coverage, and cash reserves — metrics that better capture bank solvency than manufacturing-oriented ratios. CME scores 2.96, placing it in the Grey Zone (safe > 3.0, distress < 1.5). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CME scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CME's score of -3.62 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CME's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CME receives an estimated rating of AA- (score: 83.6/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CME's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
23.94x
PEG
1.28x
P/S
15.14x
P/B
3.96x
P/FCF
21.79x
P/OCF
21.30x
EV/EBITDA
14.46x
EV/Revenue
13.63x
EV/EBIT
15.09x
EV/FCF
22.05x
Earnings Yield
4.68%
FCF Yield
4.59%
Shareholder Yield
6.56%
Graham Number
$143.00
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 23.9x earnings, CME commands a growth premium. Graham's intrinsic value formula yields $143.00 per share, 105% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.763
NI / EBT
×
Interest Burden
0.916
EBT / EBIT
×
EBIT Margin
0.903
EBIT / Rev
×
Asset Turnover
0.037
Rev / Assets
×
Equity Multiplier
6.927
Assets / Equity
=
ROE
16.1%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CME's ROE of 16.1% is driven by financial leverage (equity multiplier: 6.93x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
13.11%
Fair P/E
34.72x
Intrinsic Value
$426.07
Price/Value
0.61x
Margin of Safety
38.51%
Premium
-38.51%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CME's realized 13.1% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. CME trades at a -39% premium to its adjusted intrinsic value of $426.07, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 34.7x compares to the current market P/E of 23.9x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$293.48
Median 1Y
$305.91
5th Pctile
$199.03
95th Pctile
$471.77
Ann. Volatility
26.6%
Analyst Target
$316.73
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Lynne C. Fitzpatrick
President and Chief Financial Officer
$750,000 $2,497,729 $4,752,142
Derek L. Sammann
Global Head of Commodities Markets
$525,000 $1,748,451 $3,390,974
Julie M. Winkler
Chief Commercial Officer
$525,000 $1,748,451 $3,379,744
Sunil K. Cutinho
Chief Information Officer
$525,000 $1,748,451 $3,376,706

CEO Pay Ratio

617:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $23,945,589
Avg Employee Cost (SGA/emp): $38,839
Employees: 3,875

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
3,875
+3.1% YoY
Revenue / Employee
$1,682,735
Rev: $6,520,600,000
Profit / Employee
$1,043,716
NI: $4,044,400,000
SGA / Employee
$38,839
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
ROE 9.8% 10.2% 10.7% 9.6% 9.9% 10.4% 10.7% 10.8% 12.0% 11.7% 11.9% 12.3% 13.2% 13.4% 13.6% 13.3% 14.6% 15.8% 15.7% 16.1% 16.08%
ROA 1.6% 1.5% 1.6% 1.5% 1.5% 1.5% 1.8% 2.0% 2.1% 2.1% 2.4% 2.6% 2.6% 2.5% 2.5% 2.3% 2.4% 2.4% 2.3% 2.3% 2.32%
ROIC 7.4% 7.5% 7.7% 7.8% 8.5% 8.1% 8.3% 8.5% 9.8% 9.3% 9.7% 10.3% 11.3% 10.9% 11.3% 11.1% 11.5% 12.2% 12.2% 12.6% 12.62%
ROCE 9.7% 9.9% 10.2% 9.6% 10.0% 10.5% 10.8% 11.0% 11.9% 11.9% 12.1% 12.5% 13.4% 13.3% 13.5% 13.4% 2.7% 15.9% 14.5% 17.5% 17.50%
Gross Margin 82.4% 86.2% 85.0% 84.6% 84.0% 85.8% 84.9% 84.6% 85.2% 86.2% 86.6% 86.2% 85.5% 87.4% 86.9% 84.5% 85.4% 88.1% 69.2% 94.0% 94.00%
Operating Margin 55.1% 63.8% 60.6% 60.2% 55.3% 63.4% 61.7% 61.3% 60.0% 64.5% 65.3% 64.6% 62.1% 67.5% 66.7% 63.3% 61.8% 69.7% 64.9% 65.7% 65.70%
Net Margin 54.5% 52.8% 53.5% 55.4% 52.8% 61.3% 57.2% 56.1% 56.6% 57.5% 57.6% 57.6% 57.3% 58.2% 59.8% 59.1% 70.8% 61.4% 61.1% 59.7% 59.68%
EBITDA Margin 81.6% 78.0% 80.6% 82.3% 79.3% 89.2% 84.2% 82.4% 78.6% 83.2% 83.4% 82.1% 80.0% 83.4% 86.2% 84.8% 96.4% 87.1% 55.5% 1.4% 1.38%
FCF Margin 48.5% 51.8% 54.0% 53.4% 59.1% 60.2% 59.3% 61.9% 60.5% 59.8% 60.2% 60.0% 58.7% 60.9% 63.7% 63.8% 64.3% 64.1% 62.2% 61.8% 61.84%
OCF Margin 51.2% 54.3% 56.1% 55.3% 60.9% 61.8% 60.9% 63.4% 61.9% 61.2% 61.6% 61.5% 60.2% 62.3% 65.1% 65.0% 65.6% 65.4% 63.6% 63.3% 63.25%
ROE 3Y Avg snapshot only 14.05%
ROE 5Y Avg snapshot only 12.49%
ROA 3Y Avg snapshot only 2.27%
ROIC 3Y Avg snapshot only 10.47%
ROIC Economic snapshot only 11.70%
Cash ROA snapshot only 2.30%
Cash ROIC snapshot only 15.95%
CROIC snapshot only 15.59%
NOPAT Margin snapshot only 50.06%
Pretax Margin snapshot only 82.78%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 6.48%
SBC / Revenue snapshot only 1.42%
Valuation
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
P/E Ratio 26.55 26.41 21.66 20.58 20.07 21.62 20.23 21.49 22.02 22.84 20.30 21.84 23.27 25.98 26.19 25.84 24.32 25.29 18.72 21.35 23.938
P/S Ratio 14.93 15.31 13.09 11.11 10.76 12.10 11.51 12.25 12.73 12.98 11.57 12.52 13.39 15.00 15.27 15.15 15.09 15.87 11.81 13.48 15.136
P/B Ratio 2.55 2.64 2.26 1.95 2.01 2.26 2.17 2.33 2.66 2.69 2.43 2.68 3.10 3.49 3.55 3.44 3.42 4.03 3.02 3.54 3.956
P/FCF 30.77 29.57 24.22 20.80 18.21 20.11 19.39 19.79 21.03 21.71 19.21 20.86 22.81 24.63 23.95 23.73 23.46 24.78 18.99 21.79 21.793
P/OCF 29.14 28.19 23.32 20.09 17.67 19.59 18.88 19.32 20.56 21.20 18.78 20.36 22.23 24.07 23.45 23.29 23.00 24.27 18.56 21.30 21.305
EV/EBITDA 17.96 18.25 15.37 14.10 13.60 14.98 14.03 14.81 15.31 16.21 14.43 15.49 16.37 18.60 18.64 18.27 17.06 18.06 14.81 14.46 14.456
EV/Revenue 15.03 15.58 13.39 11.36 10.88 12.45 11.78 12.44 12.80 13.31 11.83 12.69 13.45 15.30 15.47 15.28 14.97 16.01 11.98 13.63 13.633
EV/EBIT 19.91 20.11 16.86 15.53 14.95 16.36 15.27 16.09 16.56 17.54 15.56 16.63 17.54 19.88 19.88 19.48 17.92 18.93 15.60 15.09 15.093
EV/FCF 30.99 30.09 24.77 21.25 18.42 20.69 19.86 20.10 21.15 22.27 19.64 21.14 22.93 25.13 24.27 23.94 23.27 24.99 19.26 22.05 22.047
Earnings Yield 3.8% 3.8% 4.6% 4.9% 5.0% 4.6% 4.9% 4.7% 4.5% 4.4% 4.9% 4.6% 4.3% 3.8% 3.8% 3.9% 4.1% 4.0% 5.3% 4.7% 4.68%
FCF Yield 3.3% 3.4% 4.1% 4.8% 5.5% 5.0% 5.2% 5.1% 4.8% 4.6% 5.2% 4.8% 4.4% 4.1% 4.2% 4.2% 4.3% 4.0% 5.3% 4.6% 4.59%
PEG Ratio snapshot only 1.281
EV/OCF snapshot only 21.553
EV/Gross Profit snapshot only 16.167
Acquirers Multiple snapshot only 20.764
Shareholder Yield snapshot only 6.56%
Graham Number snapshot only $143.00
Leverage & Solvency
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Current Ratio 1.01 1.02 1.02 1.02 1.01 1.02 1.02 1.03 1.02 1.01 1.02 1.02 1.01 1.02 1.02 1.02 92.97 1.02 1.02 1.02 1.019
Quick Ratio 1.01 1.02 1.02 1.02 1.01 1.02 1.02 1.03 1.02 1.01 1.02 1.02 1.01 1.02 1.02 1.02 92.97 1.02 1.02 1.02 1.019
Debt/Equity 0.13 0.12 0.12 0.12 0.13 0.13 0.12 0.12 0.13 0.13 0.12 0.12 0.13 0.13 0.12 0.12 0.13 0.13 0.13 0.13 0.129
Net Debt/Equity 0.02 0.05 0.05 0.04 0.02 0.06 0.05 0.04 0.02 0.07 0.05 0.04 0.02 0.07 0.05 0.03 -0.03 0.03 0.04 0.04 0.041
Debt/Assets 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.018
Debt/EBITDA 0.88 0.84 0.81 0.86 0.86 0.81 0.78 0.76 0.73 0.74 0.72 0.69 0.68 0.66 0.64 0.64 0.66 0.57 0.63 0.52 0.521
Net Debt/EBITDA 0.13 0.31 0.35 0.30 0.15 0.42 0.33 0.23 0.09 0.40 0.32 0.20 0.08 0.37 0.25 0.16 -0.14 0.15 0.21 0.17 0.167
Interest Coverage 21.21 22.07 23.14 22.02 22.45 24.30 25.19 25.91 27.06 26.78 27.67 28.83 29.22 29.72 30.10 29.45 31.40 32.59 59.31 72.22 72.224
Equity Multiplier 7.18 7.42 6.31 6.32 6.48 6.06 5.44 4.46 4.85 4.86 4.46 4.88 5.19 5.84 6.49 6.64 6.91 7.59 7.34 7.23 7.232
Cash Ratio snapshot only 0.015
Debt Service Coverage snapshot only 75.405
Cash to Debt snapshot only 0.680
FCF to Debt snapshot only 1.259
Defensive Interval snapshot only 874.3 days
Efficiency & Turnover
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Asset Turnover 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.04 0.04 0.04 0.04 0.05 0.05 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.037
Inventory Turnover — — — — — — — — — — — — — — — — — — — — —
Receivables Turnover 10.47 8.28 8.87 9.44 10.94 7.68 8.86 9.39 10.95 8.32 9.67 10.18 11.06 8.99 10.17 10.06 10.76 7.92 9.53 9.74 9.745
Payables Turnover 14.17 12.04 12.03 9.18 8.85 8.68 12.03 10.87 7.82 7.97 11.00 9.17 9.97 8.06 9.03 8.66 11.96 10.52 15.30 15.33 15.330
DSO 35 44 41 39 33 48 41 39 33 44 38 36 33 41 36 36 34 46 38 37 37.5 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 26 30 30 40 41 42 30 34 47 46 33 40 37 45 40 42 31 35 24 24 23.8 days
Cash Conversion Cycle 9 14 11 -1 -8 5 11 5 -13 -2 5 -4 -4 -5 -5 -6 3 11 14 14 13.6 days
Fixed Asset Turnover snapshot only 20.585
Cash Velocity snapshot only 2.993
Capital Intensity snapshot only 27.551
Growth (YoY)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue -4.0% 3.6% 5.0% 6.9% 7.0% 6.9% 8.2% 7.8% 11.1% 10.0% 10.7% 13.0% 9.9% 11.7% 11.2% 5.8% 6.4% 7.5% 5.1% 9.0% 8.99%
Net Income 25.2% 44.9% 52.3% 10.0% 2.1% 3.3% 1.8% 13.9% 19.9% 11.7% 10.9% 13.7% 9.3% 13.4% 13.7% 8.2% 14.7% 17.0% 13.7% 17.3% 17.33%
EPS 25.1% 44.8% 52.2% 9.9% 2.0% 3.2% 1.8% 13.8% 19.7% 11.5% 10.8% 13.5% 9.2% 13.3% 13.6% 8.1% 14.7% 16.0% 13.1% 17.9% 17.88%
FCF -9.6% 4.2% 38.6% 19.1% 30.4% 24.3% 18.8% 24.9% 13.9% 9.3% 12.4% 9.6% 6.5% 13.8% 17.6% 12.6% 16.6% 13.2% 2.6% 5.6% 5.57%
EBITDA 17.1% 31.7% 33.9% 8.3% 2.3% 4.1% 4.3% 12.5% 16.2% 8.7% 8.0% 10.2% 8.0% 11.9% 12.6% 8.1% 13.5% 15.9% 2.4% 22.9% 22.88%
Op. Income 0.3% 15.7% 17.0% 17.8% 14.0% 10.5% 10.7% 8.8% 13.9% 13.4% 15.3% 18.7% 14.4% 17.2% 15.5% 8.0% 7.6% 8.6% 4.8% 10.1% 10.12%
OCF Growth snapshot only 5.99%
Asset Growth snapshot only 2.64%
Equity Growth snapshot only -5.78%
Debt Growth snapshot only 0.11%
Shares Change snapshot only -0.47%
Dividend Growth snapshot only 18.70%
Growth (CAGR)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue 3Y 2.9% 3.0% 1.8% -0.0% 1.0% -0.6% 0.8% 2.8% 4.5% 6.8% 7.9% 9.2% 9.3% 9.5% 10.0% 8.9% 9.1% 9.7% 8.9% 9.2% 9.25%
Revenue 5Y 5.5% 5.9% 6.1% 6.3% 6.6% 6.0% 5.8% 6.1% 5.3% 5.1% 4.8% 4.0% 4.7% 3.8% 4.7% 5.4% 6.0% 7.9% 8.0% 8.5% 8.48%
EPS 3Y 9.6% 14.1% 17.3% 9.5% 8.2% 6.2% 7.7% 12.2% 15.2% 18.6% 19.7% 12.4% 10.1% 9.3% 8.6% 11.8% 14.4% 13.6% 12.5% 13.1% 13.11%
EPS 5Y 10.2% 10.9% 10.8% 11.1% -8.9% -8.6% -8.5% -8.5% 10.0% 11.3% 12.7% 11.2% 10.6% 8.6% 9.5% 11.7% 13.8% 17.0% 17.1% 12.6% 12.59%
Net Income 3Y 10.3% 14.2% 17.4% 9.6% 8.3% 6.3% 7.8% 12.3% 15.3% 18.7% 19.8% 12.5% 10.2% 9.4% 8.7% 11.9% 14.5% 14.0% 12.8% 13.0% 13.01%
Net Income 5Y 11.4% 12.1% 12.0% 12.3% -7.9% -7.6% -7.6% -7.6% 10.5% 11.4% 12.8% 11.3% 10.7% 8.7% 9.6% 11.8% 13.9% 17.3% 17.3% 12.6% 12.56%
EBITDA 3Y 7.2% 9.4% 10.3% 5.8% 6.3% 4.9% 6.6% 9.3% 11.6% 14.2% 14.7% 10.3% 8.7% 8.2% 8.2% 10.2% 12.5% 12.1% 7.6% 13.5% 13.55%
EBITDA 5Y 8.3% 8.2% 8.3% 6.8% 7.1% 7.7% 7.6% 8.2% 7.9% 8.2% 8.6% 8.0% 8.6% 7.0% 8.1% 9.3% 11.3% 14.1% 11.7% 12.3% 12.26%
Gross Profit 3Y 1.8% 3.0% 2.5% 1.0% 2.4% 0.1% 1.5% 3.7% 5.7% 8.6% 9.9% 11.1% 11.1% 10.9% 11.1% 9.5% 9.6% 10.4% 7.7% 9.0% 9.01%
Gross Profit 5Y 4.9% 5.8% 6.1% 6.5% 6.9% 6.1% 5.7% 6.1% 5.4% 5.6% 5.6% 5.0% 5.9% 4.6% 5.6% 6.3% 6.9% 9.3% 8.2% 9.2% 9.18%
Op. Income 3Y 0.5% 3.6% 4.1% 3.8% 5.2% 1.7% 3.4% 6.3% 9.2% 13.2% 14.3% 15.0% 14.1% 13.7% 13.8% 11.7% 11.9% 13.0% 11.7% 12.2% 12.20%
Op. Income 5Y 3.7% 4.5% 4.7% 5.2% 5.5% 4.6% 4.7% 5.4% 5.7% 6.9% 7.6% 7.6% 8.7% 6.9% 8.1% 9.1% 9.9% 13.0% 12.6% 12.6% 12.61%
FCF 3Y -0.7% 5.0% 8.9% 5.9% 6.9% 6.9% 0.4% 8.7% 10.3% 12.2% 22.8% 17.7% 16.5% 15.6% 16.2% 15.5% 12.2% 12.0% 10.7% 9.2% 9.20%
FCF 5Y 7.0% 8.8% 8.9% 8.5% 11.0% 8.3% 6.3% 7.1% 7.8% 9.5% 11.5% 10.2% 8.2% 8.7% 6.0% 9.6% 10.7% 12.7% 17.4% 14.2% 14.15%
OCF 3Y -0.5% 4.4% 6.7% 3.6% 4.6% 4.6% -0.8% 6.9% 8.3% 10.4% 19.8% 15.8% 15.4% 14.6% 15.6% 14.9% 11.9% 11.8% 10.5% 9.2% 9.15%
OCF 5Y 7.0% 8.7% 8.6% 8.3% 10.7% 8.0% 6.2% 6.8% 7.2% 8.6% 9.8% 8.6% 6.7% 7.2% 5.1% 8.4% 9.5% 11.5% 15.7% 13.0% 12.99%
Assets 3Y 36.4% 42.2% 35.9% 31.0% 32.3% 6.4% 8.9% -0.0% 1.3% -6.3% -11.6% -9.6% -11.3% -8.5% 0.6% 1.6% 4.5% 6.8% 8.8% 15.2% 15.21%
Assets 5Y 23.2% 22.2% 17.6% 17.9% 18.1% 18.9% 16.9% 12.3% 10.9% 13.0% 11.9% 11.7% 12.8% 2.7% 8.9% 8.3% 9.8% 4.7% 1.7% 0.6% 0.56%
Equity 3Y 1.9% 2.0% 1.9% 1.8% 0.9% 1.0% 1.2% 1.4% 0.5% 0.8% 1.1% 1.1% -1.1% -0.9% -0.3% -0.1% 2.2% -0.9% -1.6% -1.9% -1.92%
Book Value 3Y 1.2% 1.9% 1.8% 1.7% 0.9% 0.9% 1.1% 1.3% 0.4% 0.7% 1.0% 1.0% -1.2% -1.0% -0.4% -0.2% 2.1% -1.3% -1.8% -1.8% -1.83%
Dividend 3Y 0.6% 5.6% 5.9% 6.1% 6.3% 7.4% 7.3% 7.1% 7.0% 4.0% 3.8% 3.6% 3.4% 2.6% 2.8% 2.9% 3.0% 1.7% 1.6% 5.8% 5.81%
Growth Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue Stability 0.76 0.59 0.61 0.57 0.68 0.51 0.62 0.83 0.83 0.89 0.78 0.56 0.70 0.51 0.66 0.84 0.90 0.96 0.98 0.99 0.988
Earnings Stability 0.00 0.00 0.00 0.00 0.11 0.08 0.06 0.09 0.90 0.79 0.81 0.97 0.94 0.82 0.83 0.99 0.97 0.95 0.94 0.98 0.981
Margin Stability 0.98 0.99 0.99 0.99 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.97 0.97 0.98 0.978
Rev. Growth Consistency 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.90 0.82 0.50 0.96 0.99 0.99 0.99 0.94 0.92 0.95 0.96 0.95 0.96 0.95 0.95 0.97 0.94 0.93 0.95 0.93 0.931
Earnings Smoothness 0.78 0.63 0.59 0.90 0.98 0.97 0.98 0.87 0.82 0.89 0.90 0.87 0.91 0.87 0.87 0.92 0.86 0.84 0.87 0.84 0.841
ROE Trend 0.02 0.02 0.02 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.02 0.02 0.02 0.02 0.01 0.03 0.03 0.04 0.038
Gross Margin Trend 0.00 0.01 0.02 0.03 0.03 0.03 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 -0.04 -0.02 -0.018
FCF Margin Trend -0.02 0.02 0.04 0.03 0.09 0.09 0.12 0.11 0.07 0.04 0.04 0.02 -0.01 0.01 0.04 0.03 0.05 0.04 0.00 -0.00 -0.001
Sustainable Growth Rate 1.7% 0.9% 1.3% 0.3% 0.2% -0.9% -0.7% -0.5% -0.0% -1.2% -0.9% -0.4% -0.2% -0.7% -0.4% -0.5% 0.4% 0.7% 0.7% -0.7% -0.74%
Internal Growth Rate 0.3% 0.1% 0.2% 0.0% 0.0% — — — — — — — — — — — 0.1% 0.1% 0.1% — —
Cash Flow Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
OCF/Net Income 0.91 0.94 0.93 1.02 1.14 1.10 1.07 1.11 1.07 1.08 1.08 1.07 1.05 1.08 1.12 1.11 1.06 1.04 1.01 1.00 1.002
FCF/OCF 0.95 0.95 0.96 0.97 0.97 0.97 0.97 0.98 0.98 0.98 0.98 0.98 0.97 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.978
FCF/Net Income snapshot only 0.980
OCF/EBITDA snapshot only 0.671
CapEx/Revenue 2.7% 2.6% 2.1% 1.9% 1.8% 1.6% 1.6% 1.5% 1.4% 1.4% 1.4% 1.5% 1.5% 1.4% 1.4% 1.2% 1.3% 1.3% 1.4% 1.4% 1.42%
CapEx/Depreciation snapshot only 0.356
Accruals Ratio 0.00 0.00 0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.000
Sloan Accruals snapshot only -0.002
Cash Flow Adequacy snapshot only 0.938
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Dividend Yield 3.1% 3.4% 4.0% 4.7% 4.9% 5.0% 5.2% 4.9% 4.6% 4.8% 5.3% 4.7% 4.4% 4.1% 3.9% 4.0% 4.0% 3.8% 5.1% 4.9% 3.85%
Dividend/Share $6.10 $7.00 $7.12 $7.23 $7.33 $8.70 $8.80 $8.90 $9.00 $9.81 $9.86 $9.90 $9.95 $10.61 $10.71 $10.81 $10.92 $11.19 $11.25 $12.84 $11.30
Payout Ratio 83.0% 90.7% 87.4% 97.0% 97.9% 1.1% 1.1% 1.0% 1.0% 1.1% 1.1% 1.0% 1.0% 1.1% 1.0% 1.0% 97.2% 95.8% 95.4% 1.0% 1.05%
FCF Payout Ratio 96.2% 1.0% 97.7% 98.0% 88.8% 1.0% 1.0% 96.6% 95.8% 1.0% 1.0% 98.3% 99.7% 99.9% 94.0% 95.4% 93.8% 93.9% 96.8% 1.1% 1.07%
Total Payout Ratio 84.2% 91.5% 88.2% 97.8% 98.8% 1.1% 1.1% 1.1% 1.0% 1.1% 1.1% 1.0% 1.0% 1.1% 1.0% 1.0% 1.0% 1.1% 1.3% 1.4% 1.40%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.07 0.22 0.23 0.25 0.25 0.29 0.29 0.28 0.27 0.18 0.17 0.16 0.15 0.12 0.13 0.13 0.14 0.10 0.11 0.23 0.230
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.3% 0.8% 1.9% 1.7% 1.66%
Net Buyback Yield -1.3% -1.3% -1.5% -1.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.3% 0.8% 1.9% 1.7% 1.66%
Total Shareholder Return 1.8% 2.1% 2.5% 3.0% 4.9% 5.1% 5.3% 4.9% 4.6% 4.9% 5.3% 4.8% 4.4% 4.1% 4.0% 4.1% 4.3% 4.5% 7.0% 6.6% 6.56%
DuPont Factors
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Tax Burden (NI/EBT) 0.78 0.78 0.80 0.77 0.77 0.77 0.77 0.77 0.78 0.78 0.78 0.78 0.78 0.78 0.77 0.77 0.76 0.76 0.76 0.76 0.763
Interest Burden (EBT/EBIT) 0.95 0.95 0.96 0.95 0.96 0.96 0.96 0.96 0.96 0.96 0.96 0.97 0.97 0.97 0.97 0.97 0.98 0.98 1.08 0.92 0.916
EBIT Margin 0.75 0.77 0.79 0.73 0.73 0.76 0.77 0.77 0.77 0.76 0.76 0.76 0.77 0.77 0.78 0.78 0.84 0.85 0.77 0.90 0.903
Asset Turnover 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.04 0.04 0.04 0.04 0.05 0.05 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.037
Equity Multiplier 5.98 6.76 6.49 6.58 6.83 6.75 5.88 5.39 5.67 5.47 4.95 4.67 5.02 5.35 5.48 5.76 6.09 6.71 6.90 6.93 6.927
Per Share
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
EPS (Diluted TTM) $7.34 $7.72 $8.14 $7.45 $7.49 $7.97 $8.29 $8.48 $8.97 $8.89 $9.18 $9.63 $9.79 $10.07 $10.42 $10.41 $11.23 $11.68 $11.79 $12.27 $12.27
Book Value/Share $76.32 $77.22 $77.95 $78.63 $74.83 $76.21 $77.39 $78.28 $74.34 $75.46 $76.79 $78.38 $73.56 $75.04 $76.99 $78.23 $79.75 $73.29 $73.21 $74.06 $74.19
Tangible Book/Share $-10.68 $-9.51 $-8.46 $-7.44 $-11.27 $-9.74 $-8.37 $-7.22 $-11.07 $-9.73 $-8.23 $-6.57 $-11.10 $-9.49 $-7.46 $1.39 $-4.37 $-2.93 $-3.20 $-9.93 $-9.93
Revenue/Share $13.06 $13.32 $13.48 $13.80 $13.97 $14.23 $14.57 $14.87 $15.51 $15.63 $16.11 $16.79 $17.03 $17.45 $17.89 $17.75 $18.10 $18.61 $18.70 $19.44 $19.47
FCF/Share $6.34 $6.90 $7.28 $7.38 $8.26 $8.57 $8.65 $9.21 $9.39 $9.35 $9.70 $10.08 $9.99 $10.62 $11.40 $11.33 $11.64 $11.92 $11.63 $12.02 $12.10
OCF/Share $6.69 $7.24 $7.56 $7.63 $8.51 $8.79 $8.88 $9.43 $9.60 $9.57 $9.92 $10.33 $10.25 $10.87 $11.65 $11.55 $11.87 $12.17 $11.90 $12.30 $12.36
Cash/Share $8.22 $6.00 $5.50 $6.18 $7.84 $4.65 $5.53 $6.69 $8.41 $4.33 $5.31 $6.76 $8.35 $4.22 $5.83 $7.13 $12.63 $6.93 $6.28 $6.50 $6.51
EBITDA/Share $10.94 $11.37 $11.74 $11.12 $11.18 $11.83 $12.24 $12.49 $12.97 $12.84 $13.20 $13.75 $14.00 $14.35 $14.84 $14.85 $15.88 $16.49 $15.12 $18.33 $18.33
Debt/Share $9.60 $9.57 $9.57 $9.56 $9.57 $9.57 $9.53 $9.52 $9.52 $9.52 $9.52 $9.52 $9.52 $9.49 $9.49 $9.49 $10.43 $9.42 $9.45 $9.55 $9.55
Net Debt/Share $1.38 $3.57 $4.07 $3.38 $1.73 $4.92 $4.00 $2.84 $1.12 $5.19 $4.21 $2.76 $1.17 $5.28 $3.67 $2.36 $-2.20 $2.50 $3.17 $3.05 $3.05
Academic Models
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Altman-B Score — — — — — — — — — — — — — — — — — — — — 2.958
Altman Z-Prime snapshot only 1.022
Piotroski F-Score 4 5 5 7 7 6 6 7 7 6 6 7 7 8 5 4 5 7 6 8 8
Beneish M-Score -2.50 -2.37 -2.32 -2.24 -2.41 -2.32 -2.46 -2.47 -2.33 -2.56 -2.45 -2.35 -2.41 -2.28 -2.41 -2.52 -1.15 -2.31 -2.21 -3.62 -3.622
Ohlson O-Score snapshot only -6.791
Net-Net WC snapshot only $-17.83
EVA snapshot only $724984482.83
Credit
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Credit Rating snapshot only AA-
Credit Score 73.05 70.60 77.04 73.92 74.82 78.03 82.87 85.25 88.15 86.65 89.64 86.77 88.41 83.70 84.68 83.09 82.65 78.36 79.55 83.61 83.613
Credit Grade snapshot only 4
Credit Trend snapshot only 0.522
Implied Spread (bps) snapshot only 100.000
Industry Credit Rank snapshot only 75
Sector Credit Rank snapshot only 75

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms